Plasma Fractionation Companies
Discover Plasma Fractionation companies specializing in plasma-derived therapies, including immunoglobulins, albumin, and clotting factor products.
Sorted by Revenue (Highest to Lowest). Click any column header to re-sort.
| S.No. | Company Profile | Revenue | Operating Profit | Operating Cash Flow | ROE | Cash ROE | Updated | Action |
|---|---|---|---|---|---|---|---|---|
| 1. | CSL Limited (ASX: CSL) | A$15.56 B | A$4.13 B | — | 14.65 % | — | Oct 20, 2026 | View Data |
| 2. | Grifols, S.A. (BME: GRF) | $7.52 B | $1.24 B | $1.05 B | 5.29 % | 13.77 % | Oct 20, 2026 | View Data |
| 3. | ADMA Biologics, Inc. (NASDAQ: ADMA) | $510.17 M | — | — | — | — | Oct 20, 2026 | View Data |